September 01, 2013
1 min read
Save

CELLWAVE

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study of targeted cardiac shock wave pretreatment of bone marrow-derived mononuclear cells on recovery of left ventricular ejection fraction in patients with chronic HF.

CELLWAVE